Background
Methods
Patients
Microbiological studies
Statistical analysis
Results
Observational case series
Case | Age range/Sex | Laterality | Underlying medical condition | Initial symptom | Referring doctor | Number of days between the onset of ocular symptoms and the initial examination by ophthalmologists | Culture testing | Infection focuses | Antibiotics | Surgery | Re-operations | Visual acuity | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Blood | Ocular sample | Others | Systemic | Intravitreal | Initial | Final (follow up weeks) | ||||||||||
1 | 70-75/[1] | R | DM, uterine cancer | Fever, visual disturbance | Physician | 0 | (+) | Vitreous (+) | Urine (+) | Peritonitis | IPM/CS | VCM+CAZ | PPV+PEA | (-) | 0.03 | 1.0 (35) |
2 | 80-85/[2] | L | Gastric cancer | Fever, visual disturbance | Surgeon | 4 | (+) | N.D | N.D | Catheter-associated infection | CEZ | Not performed | (-) | (-) | 0.03 | 0.8 (77) |
3 | 70-75/[1] | L | DM, cardiac disease, rheumatoid arthritis | Fever, visual disturbance | Physician | 0 | (+) | N.D | N.D | Endocarditis | IPM/CS | Not performed | (-) | (-) | CF | 1.0 (32) |
4 | 80-85/[1] | L | Uterine cancer | Fatigue, Anorexia | Ophthalmologist | 1 | (-) | Aqueous (+), Vitreous (+) | Urine (-) | UTI | ABPC | VCM+CAZ | PPV | (-) | HM | LP (15) |
5 | 60-65/[1] | R | DM | Fatigue, Anorexia | Ophthalmologist | 0 | (+) | Aqueous (-), Vitreous (-) | Urine (+) | UTI, cellulitis, arthritis | ABPC | VCM+CAZ+VRCZ | PPV+IOL removal | PPV for RRD | 0.01 | 0.5 (9) |
6 | 70-75/[1] | R | DM | Algor | Ophthalmologist | 1 | (+) | Aqueous (+), Vitreous (+) | Urine (+) | UTI, cellulitis | ABPC | VCM+CAZ+VRCZ | Anterior chamber irrigation | PPV→ evisceration | LP | Evisceration (1) |
Antibiotics/case | 1 | 2 | 3 | 4 | 5 | 6 |
---|---|---|---|---|---|---|
Penicillin-G | S | S | S | N/A | S | S |
Ampicillin | S | S | S | S | S | S |
Cefazolin | N/A | S | S | S | N/A | N/A |
Ceftriaxone | S | N/A | S | S | S | S |
Meropenem | N/A | S | S | N/A | S | S |
Imipenem | S | S | S | S | N/A | N/A |
Vancomycin | N/A | S | S | S | S | S |
Erythromycin | S | N/A | N/A | N/A | S | S |
Clarithromycin | N/A | S | R | N/A | S | N/A |
Clindamycin | N/A | S | R | S | S | S |
Minocycline | N/A | S | I | R | N/A | S |
Arbekacin | N/A | R | R | N/A | NA | NA |
Levofloxacin | R | N/A | R | S | R | R |
Literature review
Parameters and history | Visual outcome | P value | |
---|---|---|---|
Loss of vision N = 26 | More than LP N = 17 | ||
Age ≥ 80 | 6/26 (23%) | 3/17 (18%) | NS |
Initial visual acuity ≤ CF | 24/26 (92%) | 8/17 (47%) | 0.003 |
Focuses | East Asia n = 22 | West n = 19 | Total n = 41 |
---|---|---|---|
Endocarditis | 6 (27%) | 9 (47%) | 15 (37%) |
Arthritis | 7 (32%) | 6 (32%) | 13 (32%) |
Cellulitis | 6 (27%) | 2 (11%) | 8 (20%) |
Urinary tract infection | 3 (14%) | 3 (16%) | 6 (15%) |
Pneumonia | 2 (9%) | 2 (11%) | 4 (10%) |
Meningitis | 1 (5%) | 2 (11%) | 3 (7%) |
Osteomyelitis | 2 (9%) | 0 | 2 (5%) |
Periodontitis | 2 (9%) | 0 | 2 (5%) |
Pharyngitis | 0 | 2 (11%) | 2 (5%) |
Peritonitis | 1 (5%) | 0 | 1 (2%) |
Cervical epidural abscess | 1 (5%) | 0 | 1 (2%) |
Catheter-associated infection | 1 (5%) | 0 | 1 (2%) |
Diverticulitis | 0 | 1 (5%) | 1 (2%) |
Endoarteritis | 0 | 1 (5%) | 1 (2%) |
Unknown | 0 | 1 (5%) | 1 (2%) |